Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/158950
Title: | The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecules |
Author: | de la Torre, Beatriz G. Albericio Palomera, Fernando |
Keywords: | Disseny de medicaments Pèptids Farmacologia Drug design Peptides Pharmacology |
Issue Date: | 27-Feb-2017 |
Publisher: | MDPI |
Abstract: | This is an analysis from a chemical point of view of the 22 drugs accepted by the FDA during 2016. The different drugs from the 2016 "harvest" have been classified according to their chemical structure: antibodies; TIDES (oligonucleotides and peptides); amino acids and natural products; drug combination; and small molecules. |
Note: | Reproducció del document publicat a: https://doi.org/10.3390/molecules22030368 |
It is part of: | Molecules, 2017, vol. 22, num. 3, p. 368 |
URI: | http://hdl.handle.net/2445/158950 |
Related resource: | https://doi.org/10.3390/molecules22030368 |
ISSN: | 1420-3049 |
Appears in Collections: | Articles publicats en revistes (Química Inorgànica i Orgànica) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
681089.pdf | 1.45 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License